CSMD1 Mutation Related to Immunity Can Be Used as a Marker to Evaluate the Clinical Therapeutic Effect and Prognosis of Patients with Esophageal Cancer
Xin Fan,1 Jianxiong Song,1 Yating Fan,1 Jiaqi Li,2 Yutao Chen,1 Huanhuan Zhu,1 Zhiyuan Zhang1 1Department of Otolaryngology-Head and Neck Surgery, The First Affiliated Hospital of Nanchang University, The First Clinical Medical College of Nanchang University, Nanchang, 330000, People’s Republic of C...
Guardado en:
Autores principales: | Fan X, Song J, Fan Y, Li J, Chen Y, Zhu H, Zhang Z |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Dove Medical Press
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/93f6f33cd0a74fd1900657bec64f2655 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
CSMD3 is Associated with Tumor Mutation Burden and Immune Infiltration in Ovarian Cancer Patients
por: Lu N, et al.
Publicado: (2021) -
<i>CSMD1</i> Mutations Are Associated with Increased Mutational Burden, Favorable Prognosis, and Anti-Tumor Immunity in Gastric Cancer
por: Taobi Huang, et al.
Publicado: (2021) -
Association of CSMD1 with Tumor Mutation Burden and Other Clinical Outcomes in Gastric Cancer
por: Wang X, et al.
Publicado: (2021) -
A Mutation-Related Long Noncoding RNA Signature of Genome Instability Predicts Immune Infiltration and Hepatocellular Carcinoma Prognosis
por: Jianhua Wu, et al.
Publicado: (2021) -
A Novel Autophagy-Related Long Non-Coding RNA Signature to Predict Prognosis and Therapeutic Response in Esophageal Squamous Cell Carcinoma
por: Shi X, et al.
Publicado: (2021)